STOCK TITAN

Owens & Minor, Inc. - OMI STOCK NEWS

Welcome to our dedicated news page for Owens & Minor (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Owens & Minor's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Owens & Minor's position in the market.

Rhea-AI Summary
Owens & Minor, Inc. (NYSE: OMI) will release its financial results for the first quarter of 2024 on May 3, 2024, before trading begins on the NYSE. A conference call for investors and analysts will be held at 8:30 a.m. ET on the same day. Participants can access the call via toll-free or toll dial-in numbers. Interested stakeholders are encouraged to join the live webcast on the company's investor relations page.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Owens & Minor, Inc. (OMI) reported strong financial results for the fourth quarter and full year 2023 with consolidated revenue of $10.3 billion, $741 million of operating cash flow, and significant debt reduction. The company showcased top-line growth, robust profit growth, and exceptional operating cash flow. The financial summary highlighted revenue, operating income, net income, and adjusted EBITDA for both periods. The fourth quarter results included consolidated revenue of $2.7 billion, operating income of $60 million, and adjusted operating income of $111 million. The company provided a financial outlook for 2024 with revenue expected to be in the range of $10.5 billion to $10.9 billion, adjusted EBITDA in the range of $550 million to $590 million, and adjusted EPS in the range of $1.40 to $1.70.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.56%
Tags
-
Rhea-AI Summary
Owens & Minor, Inc. (OMI) will release its Q4 2023 financial results on February 20, 2024, before trading begins on NYSE. An investor and analyst conference call will be held at 8:30 a.m. ET on the same day. Stakeholders can access the call via toll-free or toll dial-in numbers, along with a simultaneous live webcast. A replay of the webcast will be available on the investor relations page of the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.04%
Tags
Rhea-AI Summary
Owens & Minor, Inc. (NYSE: OMI) has unveiled its new purpose, Life Takes Care, reflecting the company's unique approach to caring for both the business and the humanity at the heart of healthcare. The President & Chief Executive Officer, Edward A. Pesicka, emphasizes the importance of defining this sense of purpose to better harness the collective strength, creativity, and compassion of the company's teammates as they continue to move the business forward.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.44%
Tags
none
-
Rhea-AI Summary
Owens & Minor, Inc. (NYSE: OMI) unveils a new five-year strategic plan targeting 20% compounded earnings growth between 2024 to 2028. The plan aims to unlock expanded profitability and growth profiles through investments, strong cash generation, and a value-enhancing capital allocation program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.46%
Tags
none
-
Rhea-AI Summary
Owens & Minor, Inc. (NYSE: OMI) will host an Investor Day on December 6th at Convene in Boston, Massachusetts. The event will feature presentations from the senior executive leadership team, sharing the Company’s strategic vision, operating and growth strategy, and multi-year financial targets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
conferences
Rhea-AI Summary
Owens & Minor, Inc. reported financial results for Q3 2023 with consolidated revenue of $2.59 billion and a net loss per common share of $(0.08). They achieved $188 million in total debt pay down and $117 million reduction in net debt. Patient Direct revenue increased by 9.1% compared to Q3 2022, while Products & Healthcare Services revenue increased by 2%. The company generated $157 million of operating cash flow in Q3 and provided a narrowed outlook for 2023 with revenue expected to be in the range of $10.3 billion to $10.4 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.08%
Tags
-
Rhea-AI Summary
Owens & Minor, Inc. to release Q3 2023 financial results on November 3, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.56%
Tags
-
Rhea-AI Summary
Owens & Minor, Inc. to release Q3 2023 financial results and host conference call on November 3, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.21%
Tags
Rhea-AI Summary
The Owens & Minor Foundation highlights its achievements in building healthier communities, focusing on environment, healthcare, and diversity. Recent efforts include supporting waterway conservation, improving family well-being, aiding disaster recovery, and advancing health for athletes. More information can be found in the 2022 ESG Report.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.11%
Tags
none
Owens & Minor, Inc.

NYSE:OMI

OMI Rankings

OMI Stock Data

1.96B
68.89M
2.62%
103.85%
7.3%
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Wholesale Trade
Link
US
Mechanicsville

About OMI

owens & minor, inc. (nyse: omi) is a leading healthcare logistics company dedicated to connecting the world of medical products to the point of care by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. owens & minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. with logistics platforms strategically located in the united states and europe, owens & minor serves markets where three quarters of global healthcare spending occurs. owens & minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, and the federal government. a fortune 500 company, owens & minor is headquartered in richmond, virginia, and has annualized revenues exceeding $9 billion. for more information about owens & minor, visit the company website at www.owens-m